Urawa, Japan

Kazuo Kubo


Average Co-Inventor Count = 5.2

ph-index = 3

Forward Citations = 55(Granted Patents)


Location History:

  • Urawa, JP (1979 - 1982)
  • Saitama, JP (1987)

Company Filing History:


Years Active: 1979-1987

Loading Chart...
9 patents (USPTO):Explore Patents

Title: Kazuo Kubo: Innovator in Heterocyclic Compounds

Introduction

Kazuo Kubo is a prominent inventor based in Urawa, Japan. He has made significant contributions to the field of chemistry, particularly in the development of novel heterocyclic compounds. With a total of nine patents to his name, Kubo's work has had a substantial impact on pharmaceutical research and development.

Latest Patents

Kubo's latest patents include innovative compounds such as 3,5-di-tert-butyl-4-hydroxyphenyl-substituted heterocyclic compounds. These compounds exhibit anti-inflammatory, anti-pyretic, analgesic, anti-arthritic, and immunoregulatory activities, making them particularly useful as antirheumatics. Another notable patent involves thiazolo[3,2-6]isoquinolines, which are nitrogen-containing heterocyclic compounds with various potential applications in medicine.

Career Highlights

Kazuo Kubo has spent a significant portion of his career at Yamanouchi Pharmaceutical Company Ltd. His work has been instrumental in advancing the understanding and application of heterocyclic compounds in therapeutic settings. Kubo's dedication to research and innovation has positioned him as a key figure in the pharmaceutical industry.

Collaborations

Throughout his career, Kubo has collaborated with esteemed colleagues such as Yasuo Isomura and Hiroshige Homma. These partnerships have fostered a collaborative environment that has led to groundbreaking discoveries in the field of chemistry.

Conclusion

Kazuo Kubo's contributions to the field of heterocyclic compounds have established him as a leading inventor in pharmaceutical research. His innovative patents and collaborations continue to influence the development of new therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…